Dobutamine/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett mNo edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
"A [[Adrenergic beta-agonist|beta-2 agonist]] catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after [[myocardial infarction]] or open heart surgery." [[National Library of Medicine]] | "A [[Adrenergic beta-agonist|beta-2 agonist]] catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after [[myocardial infarction]] or open heart surgery." ([[National Library of Medicine]]) | ||
Revision as of 02:31, 28 February 2010
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
Dobutamine [r]: "A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery." (National Library of Medicine)